ADVANCED/METASTATIC NSCLC
Clinical trials for ADVANCED/METASTATIC NSCLC explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC NSCLC trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on Hard-to-Treat lung cancer
Disease control Recruiting nowThis study tests a new treatment for people with advanced non-small cell lung cancer that has not responded to standard therapies. Participants receive specially designed natural killer (NK) immune cells that target two cancer markers at once. The goal is to see if this approach …
Matched conditions: ADVANCED/METASTATIC NSCLC
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Morning or afternoon? timing may boost cancer immunotherapy
Knowledge-focused Recruiting nowThis study looks at whether getting immunotherapy in the morning or afternoon makes a difference for people with advanced lung cancer. About 350 participants will be randomly assigned to receive their treatment either before 11 AM or after 12 PM. The goal is to see if timing affe…
Matched conditions: ADVANCED/METASTATIC NSCLC
Phase: PHASE2 • Sponsor: Liza Villaruz, MD • Aim: Knowledge-focused
Last updated May 20, 2026 11:58 UTC